BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Contrast Media and Barium Pharmaceutical Products. The scope of this Contrast Media and Barium Products Framework Agreement includes, but is not limited to the supply of:
1) Ionic contrast media
2) Non-ionic contrast media
3) Gadolinium based contrast for MRI
4) Ultrasound contrast agents
5) Iodised oil fluid
6) Oral medium for gastrointestinal tract
7) Barium sulphate contrast media
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Bayer PLC | 16954143 | ~£15,000,000 estimated from lot values | - |
| Bracco UK Ltd | 04087007 | ~£15,000,000 estimated from lot values | - |
| Clarity Pharma Ltd | 03657934 | ~£15,000,000 estimated from lot values | - |
| GE Healthcare Ltd | 01002610 | ~£15,000,000 estimated from lot values | - |
| Guerbet Laboratories Ltd | 02940474 | ~£15,000,000 estimated from lot values | - |
| Lamepro BV | - | ~£15,000,000 estimated from lot values | - |
Government spending data: These suppliers have received £10,425,342 in 1,522 payments (over £25k) from Guy's and St Thomas' NHS FT, Manchester University NHS Foundation Trust, United Lincolnshire Hospitals NHS Trust, East Sussex Healthcare NHS Trust, Department of Health and Social Care and 9 more public bodies (2018-06-18 to 2026-03-31).